Qiagen NV (QGEN) PT Raised to $43 at BofA/Merrill Lynch
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts QGEN Hot Sheet
Price: $45.56 +0.26%
Rating Summary:
15 Buy, 16 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Rating Summary:
15 Buy, 16 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Join SI Premium – FREE
BofA/Merrill Lynch analyst Derik de Bruin raised the price target on Qiagen NV (NYSE: QGEN) to $43.00 (from $40.00) while maintaining a Neutral rating following analyst day.
- Updated mid-term guide mostly in-line with our expectations
- Mid-term guide of 8-9% CER sales; ~10% EPS CAGR
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Box, Inc. (BOX) PT Raised to Street High $50 at BofA Securities, New Top Pick, 'underappreciated AI winner'
- CrowdStrike (CRWD) PT Raised to $320 at Freedom Broker
- Rocket Cos Inc. (RKT) PT Lowered to $16 at StoneX
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Derik de Bruin, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
